Abstract:The simultaneous pharmaceutical analysis of multi-component drugs represents a challenge due to a large total number of analytes present in the sample. These analytes are not only the active pharmaceutical ingredients, but also the impurities that might follow the active substances. The aim of this study was to develop an efficient reversed-phase LC method for the simultaneous analysis of antiparkinsonian drugs levodopa, carbidopa and entacapone along with their six related impurities. For the achievement of desirable separation, different acids with anions possessing different properties according to Hofmeister classification (ortho-phosphoric, trifluoroacetic and perchloric acid) were tested. Finally, in order to draw the unbiased conclusions when optimizing the analytical method, for the final tuning of the gradient program, Box-Behnken experimental design and Derringer's desirability function were used. The experiments were performed on Zorbax Extend C18, 150 mm × 4.6 mm, 5 μm particle size column with the UV detection at 280 nm and mobile phase flow rate of 1 mL/min. The optimal mobile phase consisted of methanol and 20mM trifluoroacetic acid (pH 2.0 adjusted with NaOH), while their ratio is changed according to previously defined gradient program. The method was tested for selectivity, sensitivity, linearity, accuracy and precision, and proved to be suitable for routine qualitative and quantitative analysis of levodopa, carbidopa, entacapone and their impurities in their mixture.

Enantiomeric separation and determination of antiparkinsonian drugs by reversed-phase ligand-exchange high-performance liquid chromatography

Analytical enantioseparation of N-alkyl drugs by reversed-phase liquid chromatography with carboxymethyl--cyclodextrin as mobile phase additive

Enantioseparation of Five Racemic N‐alkyl Drugs by Reverse Phase HPLC Using Sulfobutylether‐β‐cyclodextrin As a Chiral Mobile Phase Additive

An Enantiospecific HPLC Method for the Determination of (S)-Enantiomer Impurities in (R)-Tolterodine Tartarate.

Chiral phenethylamine synergistic tricarboxylic acid modified ,B-cyclodextrin immobilized on porous silica for enantioseparation

Enantioseparation of 3-phenyllactic acid by chiral ligand exchange countercurrent chromatography.

Chaotropic agents in liquid chromatographic method development for the simultaneous analysis of levodopa, carbidopa, entacapone and their impurities

Efficient Preparative Separation Of 6-(4-Aminophenyl)-5-Methyl-4, 5-Dihydro-3(2h)-Pyridazinone Enantiomers On Polysaccharide-Based Stationary Phases In Polar Organic Solvent Chromatography And Supercritical Fluid Chromatography

Separation Of Terfenadine Enantiomers By High Performance Liquid Chromatography Using Beta-Cyclodextrin As Chiral Mobile Phase Additive

Simultaneous Enantioseparation of Antiparkinsonian Medication Rotigotine and Related Chiral Impurities by Capillary Zone Electrophoresis Using Dual Cyclodextrin System.

Enantiomeric Separation of Β-Blockers by HPLC Using (R)-1-naphthylglycine and 3,5-Dinitrobenzoic Acid As Chiral Stationary Phase

Simultaneous enantioseparation of nonsteroidal anti-inflammatory drugs by a one-dimensional liquid chromatography technique using a dynamically coated chiral porous silicon pillar array column

Diastereomeric and Enantiomeric High-Performance Liquid Chromatographic Separation of Synthetic Anisodamine

Development and Validation of a Reversed-Phase HPLC Method for Determination of Lesatropane and Enantiomeric Impurity.

Establishment of Reverse-Phase High-Performance Liquid Chromatography with Chiral Reagent Derivatization for Separation of Fexofenadine Enantiomers

Separation and Analysis of Several Proton Pump Inhibitors Enantiomers by HPLC with Chiral Stationary Phase

Chiral Separation of Oxomemazine Enantiomers by HPLC Technique and Enantiomeric Separation Mechanism via Docking Studies

Chiral phenethylamine synergistic tricarboxylic acid modified β-cyclodextrin immobilized on porous silica for enantioseparation

Enantiomeric Separation of Two Antiparkinsonian Drugs by Electrokinetic Chromatography Using Dextran Sulfate

Separation and simultaneous estimation of enantiomers and Diastereomers of muscarinic receptor antagonist Solifenacin using stability-indicating Normal-phase HPLC technique with chiral stationary phase amylose tris-(3,5-dimethylphenylcarbamate)

Enantiomeric Separation of 2-Arylpropionic Acid Nonsteroidal Anti-Inflammatory Drugs by HPLC with Hydroxypropyl-Beta-cyclodextrin As Chiral Mobile Phase Additive.